Product Images Amlodipine And Valsartan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Amlodipine And Valsartan NDC 45865-889 by Medsource Pharmaceuticals, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Amlodipine & Valsartan Tablets 10/160mg are a generic medication used as a replacement for Exforge. More information about this product is not available in this text.*
This is a table displaying baseline SBP (measured in mmHg) and medication dosages for Amiodarone, Valsartan, and Kichnep tablets. The top line indicates the target SBP level (<140 mmHg).*
This appears to be a medical information sheet with information about a medication called "Amiodipine and Valsartan Tablets" and its dosage indication for the medication. It states that the medication contains 10 mg of Amiodipine and 320 mg of Valsartan. The percentage value of "DBP <90 mmHg" suggests that the medication is prescribed to manage high blood pressure. However, there is not enough information available to provide a comprehensive description, such as the recommended dosage, potential side effects, and contraindications.*
This is a graph displaying blood pressure levels of patients under various treatments. The text on the graph indicates that the target blood pressure is less than 130 mmHg. The treatments include Anbodine, Valsartan 250 mg, Valsartan 320 mg, Kaisdne 10, and Placebo. The values on the x-axis represent the baseline SBP (mmHg) of the patients, and the values on the y-axis represent the different treatments. The highest blood pressure levels observed were around 180 mmHg.*
The text describes a chart that compares the effects of Amlodipine and Valsartan on DBP (diastolic blood pressure). The chart shows that a combination of Valsartan 320 mg and Amlodipine 10 mg led to a significant reduction in DBP, compared to baseline measurements. A placebo was also used for comparison.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.